Nature's Sunshine Products (NATR)
(Real Time Quote from BATS)
$15.80 USD
+0.72 (4.78%)
Updated May 21, 2024 11:16 AM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Nature's Sunshine Products, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 445 | 422 | 444 | 385 | 362 |
Cost Of Goods | 124 | 122 | 115 | 101 | 94 |
Gross Profit | 321 | 300 | 329 | 284 | 268 |
Selling & Adminstrative & Depr. & Amort Expenses | 302 | 284 | 294 | 262 | 252 |
Income After Depreciation & Amortization | 19 | 16 | 35 | 21 | 16 |
Non-Operating Income | 2 | -1 | -3 | 1 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 20 | 15 | 32 | 23 | 16 |
Income Taxes | 4 | 15 | 2 | 0 | 9 |
Minority Interest | 1 | 1 | 1 | 2 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 16 | 1 | 30 | 23 | 7 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 15 | 0 | 29 | 21 | 7 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 31 | 27 | 46 | 32 | 27 |
Depreciation & Amortization (Cash Flow) | 12 | 11 | 11 | 11 | 11 |
Income After Depreciation & Amortization | 19 | 16 | 35 | 21 | 16 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 19.47 | 19.33 | 20.33 | 19.97 | 19.66 |
Diluted EPS Before Non-Recurring Items | 0.95 | 0.04 | 1.41 | 1.07 | 0.42 |
Diluted Net EPS (GAAP) | 0.77 | -0.02 | 1.42 | 1.07 | 0.34 |
Fiscal Year end for Nature's Sunshine Products, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 110.99 | 108.94 | 111.20 | 116.55 | 108.63 |
Cost Of Goods | 32.02 | 30.61 | 29.96 | 31.92 | 31.69 |
Gross Profit | 78.98 | 78.32 | 81.24 | 84.62 | 76.94 |
SG&A, R&D, and Dept/Amort Expenses | 74.35 | 72.61 | 75.41 | 77.59 | 76.77 |
Income After SG&A, R&D, and Dept/Amort Expenses | 4.63 | 5.71 | 5.83 | 7.03 | 0.17 |
Non-Operating Income | 0.03 | 1.47 | -0.93 | -1.09 | 1.51 |
Interest Expense | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 |
Pretax Income | 4.66 | 7.66 | 4.91 | 5.95 | 1.69 |
Income Taxes | 2.17 | -1.68 | 1.76 | 3.27 | 0.43 |
Minority Interest | 0.17 | 0.38 | 0.31 | 0.26 | 0.39 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 2.49 | 9.34 | 3.14 | 2.68 | 1.25 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 2.32 | 8.96 | 2.83 | 2.42 | 0.86 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 19.22 | 19.40 | 19.49 | 19.75 | 19.43 |
Diluted EPS Before Non-Recurring Items | 0.12 | 0.45 | 0.15 | 0.12 | 0.23 |
Diluted Net EPS (GAAP) | 0.12 | 0.46 | 0.15 | 0.12 | 0.04 |